Clinical Trial Update: Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 safety study evaluating cetuximab with radiotherapy and temozolomide for glioblastoma multiforme; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Cetuximab (cetuximab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Heidelberg University | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: UNKNOWN